Keyphrases
Therapeutic Drug Monitoring
100%
Pragmatic Clinical Trial
100%
Linezolid
100%
Rifampicin-resistant Tuberculosis
100%
Multidrug-resistant Tuberculosis (MDR-TB)
38%
Rifampicin Resistance
30%
South Africa
23%
Standard of Care
15%
Survival Rate
7%
Narrow Therapeutic Window
7%
Tuberculosis Control
7%
Extensively Drug-resistant
7%
New Drugs
7%
Antituberculosis Activity
7%
Treatment Failure
7%
Global Burden
7%
Global Epidemic
7%
Additional Resistance
7%
Drug Repurposing
7%
Treatment Regimen
7%
Trough Plasma Concentration
7%
Trough Concentration
7%
TB Treatment
7%
Drug-resistant HIV
7%
TB Drugs
7%
High Mortality Rate
7%
Drug Toxicity
7%
Patients at Risk
7%
Effective Compounds
7%
Clinical Adverse Events
7%
Drug Efficacy
7%
Inter-individual Variability
7%
Gram-positive
7%
Therapy Discontinuation
7%
Pharmacology
7%
HIV Control
7%
Hematologic
7%
Control Effort
7%
Mycobacterium Tuberculosis (M. tb)
7%
Dose Reduction
7%
Multidrug
7%
Myelosuppression
7%
Cure Rate
7%
Tuberculosis Treatment
7%
Pharmacokinetic Parameters
7%
Drug Standards
7%
Population PK
7%
Premature Discontinuation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Therapeutic Drug Monitoring
100%
Linezolid
100%
Drug Resistant Tuberculosis
100%
Rifampicin
100%
HIV
23%
Mortality Rate
7%
Randomized Clinical Trial
7%
Pharmacokinetic Parameter
7%
Therapeutic Window
7%
Prematurity
7%
Adverse Event
7%
Bone Marrow Suppression
7%
Drug Toxicity
7%